> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Guide on Drug/Biologic Covid Studies
- URL: https://www.fdaweb.com/guide-on-drug-biologic-covid-studies/
- Published: 2024-02-22T12:00:00.000Z
- Updated: 2026-09-14T14:23:40.000Z
- Author: David McFarland
- Tags: FDA Policy/General, #legacy-id-D5156415

*Federal Register* notice: FDA is making available a final guidance entitled “Assessing Covid–19-Related Symptoms in Outpatient Adult and Adolescent Subjects in Clinical Trials of Drugs and Biological Products for COVID–19 Prevention or Treatment.” The document is intended to provide sponsors and investigators with considerations for approaches on how common Covid symptoms can be measured and analyzed in clinical trials evaluating drugs or biological products for preventing/treating the disease. To view the notice, click [here](https://www.govinfo.gov/content/pkg/FR-2024-02-22/pdf/2024-03622.pdf?ref=fdaweb.com).